Philippe Martin To Advance Its Psilocybin Drug Candidates News Release (09-03-21): NeonMind (CSE: NEON) (OTC: NMDBF) Engages Pharma Executive Philippe Martin To Advance Its Psilocybin Drug Candidates For Obesity. Read Here: https://neonmindbiosciences.com/neonmind-engages-pharma-executive-philippe-martin-to-advance-its-psilocybin-drug-candidates-for-obesity/